Dr. Mark J. Mentrikoski

Mark J. Mentrikoski, MD
Anatomic and Clinical Pathology

100 North Academy Avenue
Danville, PA  17822-1920
800-695-6491

Dr. Mentrikoski is an associate at Geisinger Medical Center in Danville, Pennsylvania, where is specializes in breast, cervical,  gastrointestinal, gynecologic ,and thoracic pathology. 

Education:

Dr. Mentrikoski received his MD from the University of Rochester, School of Medicine and Dentistry in Rochester, New York.  He completed a residency in anatomic and clinical pathology at University of Virginia, Department of Pathology, Charlottesville, Virginia, and a fellowship in gynecologic pathology at Johns Hopkins Medical Institutes, Department of Pathology, Baltimore, Maryland.

Certifications:

Dr. Mentrikoski is board certified in anatomic and clinical pathology.

Professional Affiliations:

International Society of Gynecologic Pathologists
American Society for Clinical Pathology
College of American Pathologists
United States and Canadian Academy of Pathology
International Society of Urological Pathology

Research Interests:

Endometrial and ovarian malignancies.

Recent Academic Activity

Publications in Peer-Reviewed Journals:

Verduin L, Mentrikoski MJ, Heitz CT, Wick MR. The Utility of GATA3 in the Diagnosis of Urothelial Carcinomas with Variant Morphologic Patterns. Appl Imunohistochem Mol Morphol. 2016 Aug; 24(7):509-13. PMID: 26317312.

Webb DV, Mentrikoski MJ, Verduin L, Brill LB 2nd, Wick MR. Basal cell carcinoma vs basaloid squamous cell carcinoma of the skin: an immunohistochemical reappraisal. Ann Diagn Pathol. 2015 Apr; 19(2):70-5. Epub 2015 Jan 22. PMID: 25702956.

Mentrikoski MJ and Wick MR. Immunohistochemical distinction of primary sweat gland carcinoma and metastatic breast carcinoma: can it always be accomplished reliably? Am J Clin Path. 2015 Mar;143(3):430-6. PMID: 25696802.

Abstracts, Posters, and Other Presentations:

Mentrikoski MJ, Lastra R, Kurman RJ. Mullerian Adenosarcomas with Rhabdomyoblastic Differentiation Are Associated with an Aggressive Clinical Course. Platform presentation. United States and Canadian Academy of Pathology 104th Annual Meeting, March 2015, Boston, MA.

Wendroth SM, Mentrikoski MJ, Wick MR. GATA3 Expression in Morphologic Subtypes of Breast Carcinoma. Platform presentation. United States and Canadian Academy of Pathology 103rd Annual Meeting, March 2014, San Diego, CA.

Verduin L, Heitz C, Mentrikoski MJ, Wick MR. The Utility of GATA3 in the Diagnosis of Bladder Carcinoma with Variant Histology. Platform presentation. United States and Canadian Academy of Pathology 103rd Annual Meeting, March 2014, San Diego, CA.

Mentrikoski MJ, LeGallo RD, Mills SE, Stelow EB. USP6 Rearrangements Are Not Identified in Giant Cell Reparative Granulomas of the Sinonasal Tract. Presented at the United States and Canadian Academy of Pathology 103rd Annual Meeting, March 2014, San Diego, CA.

Mentrikoski MJ, Stowman AM, Stoler MH. HER2 Immunohistochemistry Significantly Overestimates HER2 Amplification in Uterine Papillary Serous Carcinomas. Presented at the United States and Canadian Academy of Pathology 103rd Annual Meeting, March 2014, San Diego, CA.

Zhao Z, Mentrikoski MJ, Bauer T, Stelow EB. Immunohistochemical Markers and Prognosis with Pancreatic Neuroendocrine Tumors. Presented at the United States and Canadian Academy of Pathology 103rd Annual Meeting, March 2014, San Diego, CA.